thymidine has been researched along with Meningeal Neoplasms in 8 studies
Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, Northern blots, immunohistochemistry, TGF beta radioreceptor assays, TGF beta receptor affinity labeling and [3H] thymidine incorporation were used to evaluate whether primary cell cultures of human meningiomas synthesize the three TGF beta isoforms, bear TGF beta receptors, and respond to TGF beta." | 7.68 | Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. ( Federspiel, CF; Gold, LI; Johnson, MD; Moses, HL, 1992) |
| " We studied the effects of BQ-123, a selective ETA receptor antagonist, on 125I-endothelin-1 (125I-ET-1) binding to cell surface receptors in surgically exercised human meningiomas and on ET-1-induced DNA synthesis in cultured human meningioma cells in vitro, using a quantitative receptor autoradiographic technique with radioluminography and 3H-thymidine incorporation, respectively." | 3.69 | A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells. ( Anda, T; Himeno, A; Khalid, H; Kitagawa, N; Niwa, M; Shibata, S; Taniyama, K; Tsutsumi, K; Yamaga, S, 1994) |
| " In this study, Northern blots, immunohistochemistry, TGF beta radioreceptor assays, TGF beta receptor affinity labeling and [3H] thymidine incorporation were used to evaluate whether primary cell cultures of human meningiomas synthesize the three TGF beta isoforms, bear TGF beta receptors, and respond to TGF beta." | 3.68 | Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. ( Federspiel, CF; Gold, LI; Johnson, MD; Moses, HL, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MD | 3 |
| Okedli, E | 1 |
| Woodard, A | 2 |
| Toms, SA | 1 |
| Allen, GS | 1 |
| Okediji, E | 1 |
| Kitagawa, N | 2 |
| Tsutsumi, K | 2 |
| Niwa, M | 2 |
| Yamaga, S | 1 |
| Anda, T | 1 |
| Khalid, H | 1 |
| Himeno, A | 2 |
| Taniyama, K | 2 |
| Shibata, S | 2 |
| Yamashita, K | 1 |
| Kurihara, M | 1 |
| Kawano, T | 1 |
| Yasunaga, A | 1 |
| Friend, KE | 1 |
| Radinsky, R | 1 |
| McCutcheon, IE | 1 |
| Federspiel, CF | 1 |
| Gold, LI | 1 |
| Moses, HL | 1 |
| Koper, JW | 1 |
| Markstein, R | 1 |
| Kohler, C | 1 |
| Kwekkeboom, DJ | 1 |
| Avezaat, CJ | 1 |
| Lamberts, SW | 1 |
| Reubi, JC | 1 |
| Kunert-Radek, J | 1 |
| Stepien, H | 1 |
| Radek, A | 1 |
| Pawlikowski, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of the Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Malignant Pleural Mesothelioma[NCT02303899] | Phase 2 | 22 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for thymidine and Meningeal Neoplasms
| Article | Year |
|---|---|
Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.
Topics: Adult; Aged; Androstadienes; Anticoagulants; Becaplermin; Enzyme Inhibitors; Female; Humans; Male; M | 2002 |
Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways.
Topics: Aged; Antibodies; Cell Division; Cerebrospinal Fluid; DNA-Binding Proteins; Female; Humans; Male; Me | 2004 |
A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.
Topics: Amino Acid Sequence; Cell Division; Endothelin Receptor Antagonists; Endothelins; Humans; Iodine Rad | 1994 |
Expression of a functional endothelin (ETA) receptor in human meningiomas.
Topics: Adolescent; Aged; Autoradiography; Binding Sites; Female; Humans; Male; Meningeal Neoplasms; Meningi | 1994 |
Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist.
Topics: Adult; Aged; Aged, 80 and over; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Humans; | 1999 |
Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells.
Topics: Blotting, Northern; Cross-Linking Reagents; Humans; Immunohistochemistry; Meningeal Neoplasms; Menin | 1992 |
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.
Topics: Adenylyl Cyclase Inhibitors; Bucladesine; Cell Division; Colforsin; Cyclic AMP; DNA Replication; Dos | 1992 |
Somatostatin suppression of meningioma cell proliferation in vitro.
Topics: Adult; Cell Division; Female; Humans; In Vitro Techniques; Meningeal Neoplasms; Meningioma; Middle A | 1987 |